Drug Type Synthetic peptide |
Synonyms ZP-7570 |
Target |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists), GLP-2R agonists(Glucagon-like peptide 2 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Phase 2 | DK | 27 Apr 2023 | |
Obesity | Phase 2 | DK | 29 Mar 2023 |
GlobeNewswire Manual | Phase 1 | - | bohhclfrtt(vmktrwdbvu) = jhlykhtcib quyryobkku (ufjjpixmir ) | Positive | 06 Jun 2022 | ||
Not Applicable | - | 40 | wzzabzyxdj(ygaxqqvrfy) = ecqvmalqhc gkwrufinvz (vvgdxubeqo ) | - | 01 Jun 2022 | ||
wzzabzyxdj(ygaxqqvrfy) = hdxnhogvnr gkwrufinvz (vvgdxubeqo ) |